Zynex Cost Of Revenue vs Capex To Revenue Analysis
ZYXI Stock | USD 7.92 0.07 0.88% |
Zynex financial indicator trend analysis is more than just analyzing Zynex Inc current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zynex Inc is a good investment. Please check the relationship between Zynex Cost Of Revenue and its Capex To Revenue accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Cost Of Revenue vs Capex To Revenue
Cost Of Revenue vs Capex To Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zynex Inc Cost Of Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Zynex's Cost Of Revenue and Capex To Revenue is -0.32. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Zynex Inc, assuming nothing else is changed. The correlation between historical values of Zynex's Cost Of Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Zynex Inc are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Cost Of Revenue i.e., Zynex's Cost Of Revenue and Capex To Revenue go up and down completely randomly.
Correlation Coefficient | -0.32 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Cost Of Revenue
Cost of Revenue is found on Zynex Inc income statement and represents the costs associated with goods and services Zynex provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most indicators from Zynex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zynex Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. As of now, Zynex's Enterprise Value Multiple is increasing as compared to previous years. The Zynex's current Enterprise Value is estimated to increase to about 353.9 M, while Sales General And Administrative To Revenue is projected to decrease to 0.29.
2022 | 2023 | 2024 | 2025 (projected) | Interest Expense | 440K | 1.1M | 1.3M | 1.3M | Depreciation And Amortization | 3.1M | 4.2M | 4.9M | 5.1M |
Zynex fundamental ratios Correlations
Click cells to compare fundamentals
Zynex Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Zynex fundamental ratios Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Common Stock Shares Outstanding | 38.4M | 43.1M | 39.1M | 36.1M | 41.6M | 28.8M | |
Total Assets | 72.2M | 133.3M | 116.5M | 136.9M | 157.4M | 165.3M | |
Total Stockholder Equity | 56.9M | 73.9M | 66.4M | 46.1M | 53.0M | 55.7M | |
Retained Earnings | 23.4M | 0.0 | 17.0M | 26.8M | 30.8M | 32.3M | |
Other Current Assets | 2.8M | 1.4M | 868K | 3.3M | 3.8M | 4.0M | |
Other Stockholder Equity | 33.4M | 73.9M | 49.3M | 19.3M | 22.2M | 23.3M | |
Total Current Assets | 63.0M | 82.7M | 69.6M | 87.9M | 101.0M | 106.1M | |
Liabilities And Stockholders Equity | 72.2M | 133.3M | 116.5M | 136.9M | 157.4M | 165.3M | |
Total Liab | 15.3M | 59.3M | 50.1M | 90.8M | 104.4M | 109.6M | |
Short Long Term Debt Total | 7.3M | 35.1M | 27.0M | 76.2M | 87.6M | 92.0M | |
Other Current Liab | 864K | 4.5M | 5.5M | 5.5M | 6.4M | 6.7M | |
Total Current Liabilities | 10.1M | 22.9M | 21.1M | 18.5M | 21.3M | 22.4M | |
Property Plant And Equipment Net | 7.9M | 18.5M | 15.0M | 16.2M | 18.6M | 19.6M | |
Net Debt | (31.8M) | (7.5M) | 6.8M | 31.6M | 28.4M | 29.9M | |
Accounts Payable | 4.7M | 4.7M | 5.6M | 8.4M | 9.7M | 10.2M | |
Non Current Assets Total | 9.2M | 50.6M | 46.9M | 49.0M | 56.4M | 59.2M | |
Net Receivables | 13.8M | 28.6M | 35.1M | 26.8M | 30.9M | 32.4M | |
Non Current Liabilities Total | 5.2M | 36.5M | 29.0M | 72.2M | 83.1M | 87.2M | |
Inventory | 8.6M | 10.8M | 13.5M | 13.1M | 15.1M | 15.8M | |
Property Plant And Equipment Gross | 7.9M | 18.5M | 15.0M | 18.4M | 21.1M | 22.2M | |
Short Term Debt | 4.3M | 11.3M | 7.9M | 3.9M | 4.5M | 3.0M | |
Property Plant Equipment | 4.9M | 1.9M | 18.9M | 2.2M | 2.5M | 3.0M | |
Non Currrent Assets Other | 668K | 974K | 861K | 409K | 470.4K | 493.9K | |
Cash | 39.2M | 42.6M | 20.1M | 44.6M | 51.3M | 53.8M | |
Other Assets | 913K | 1.3M | 2.2M | 1.0 | 1.15 | 1.09 | |
Cash And Short Term Investments | 39.2M | 42.6M | 20.1M | 44.6M | 51.3M | 53.8M | |
Net Tangible Assets | 19.7M | 56.9M | 43.5M | 36.9M | 42.4M | 44.5M | |
Retained Earnings Total Equity | 4.9M | 14.4M | 23.4M | 17.0M | 19.6M | 20.6M | |
Capital Surpluse | 9.2M | 37.2M | 80.4M | 82.4M | 94.8M | 99.5M | |
Capital Lease Obligations | 7.3M | 19.2M | 16.3M | 18.6M | 21.3M | 22.4M |
Currently Active Assets on Macroaxis
When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 0.14 | Revenue Per Share | Quarterly Revenue Growth 0.001 | Return On Assets |
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.